Question 1

Does Ubs own JSPR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 58,759 shares of JSPR (Jasper Therapeutics), worth $24,737.

Question 2

How many shares of JSPR does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 58,759 shares of JSPR (Jasper Therapeutics).

Question 3

What is Ubs' JSPR position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' JSPR position is worth $24,737.

Question 4

Is Ubs buying or selling JSPR?

Accepted Answer

In Q2 2026, Ubs reduced its JSPR position by 22,358 shares (-27.6%).

Question 5

When did Ubs first buy JSPR?

Accepted Answer

Ubs first reported JSPR in its Q2 2024 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	58,759	-27.6%	$24,737	0.0%	$0.42	0
2026-Q1	Decreased	81,117	-35.8%	$71,058	0.0%	$1.33	0
2025-Q4	Increased	126,361	+221.1%	$231,240	0.0%	$1.79	25
2025-Q3	Decreased	39,354	-90.5%	$93,662	0.0%	$2.49	0
2025-Q2	Decreased	416,275	-22.1%	$2.3M	0.0%	$5.49	0
2025-Q1	Increased	534,636	+225.4%	$2.3M	0.0%	$4.46	42
2024-Q4	Increased	164,315	+2990.4%	$3.5M	0.0%	$20.95	43
2024-Q3	Increased	5,317	+31.2%	$100,013	0.0%	$18.83	19
2024-Q2	New	4,052	-	$91,980	0.0%	$22.70	33

JSPR9 quarters

JSPR
9 quarters